# Shandong Luxi Pharmaceutical Co., Ltd. – FDA Inspection, Feb 28, 2025

Source: https://www.keypedia.com/records/fda_inspections/shandong-luxi-pharmaceutical-co-ltd/adf84eef-920e-47e9-b417-621cbd3de422
Source feed: FDA_Inspections

> FDA inspection 1263977 of Shandong Luxi Pharmaceutical Co., Ltd., February 28, 2025. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1263977
- Company Name: Shandong Luxi Pharmaceutical Co., Ltd.
- Inspection Date: 2025-02-28
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 0

## Related Documents

- [FDA Inspection 1099165 - 2019-07-24](https://www.keypedia.com/records/fda_inspections/shandong-luxi-pharmaceutical-co-ltd/de895a47-d953-4bb9-a782-5dbe88d30880)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/tekalign-wondimu/3b80e5c8-4062-4e1d-8ddd-b1afa2616dec)

Company: https://www.keypedia.com/companies/shandong-luxi-pharmaceutical-co-ltd/d676adc9-409f-4ea4-881b-d2cf1ab1e684

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8
